Company Profile

Genomic Vision is a molecular diagnostics and technology company specialized in the development of single DNA detection tools for research and in vitro diagnostics



Supervisory Board


Isabelle Racamier -  President

Mrs. Racamier is CEO of EsoCap AG, a Swiss company developing a unique drug delivery technology for diseases of the esophagus. Holding a Masters in Management from ESCP Europe (Ecole Supérieure de Commerce– Paris), she has over 25 years’ experience in the pharmaceutical and biotechnology industry in controlling, strategic planning, marketing and executive management. She has held a number of positions of responsibility in France, Switzerland, the United States, Japan and Austria with Novartis, Boehringer Mannheim/Roche and Sanofi. She was the General Manager of Sanofi in Austria from 1998 to 2005.


Elisabeth Ourliac, LLB(Hons), MBA - Vice-President

Elisabeth Ourliac is Vice President Strategy at Airbus , the leading aircraft manufacturer. Prior to this role, Elisabeth was Head of Audit and Risk for Airbus , responsible towards the audit committee of the Board (British Aerospace and EADS shareholders). Elisabeth began her professional career in an Audit firm and joined shortly after Aerospatiale, the French aerospace company which cofounded Airbus . She held various senior executive positions -eg Controller for the commercial aircraft division- in which she directly contributed to the restructuring of the European Aeronautical Industry with the merge of Aerospatiale/Matra and the creation of EADS She then closely contributed to the integration of the Airbus Company between the industrial players of the 4 nations (France, Germany, UK and Spain).
Elisabeth speaks three languages ( French, English and German ). She holds a Master of Business Administration from the Toulouse Business School, majoring in Finance. Additionally she holds a Bachelor in law from the University of Toulouse.
She is the chairman of the board of IAE (School of management of the University of Toulouse), Administrator of the Toulouse Business School foundation and plays an active role in connecting the higher education institutions with the business world and its industrial actors.
Elisabeth is a Member of the “Centre d’Etudes et de Prospective Strategique “ and co-chairs the Toulouse chapter.
She is also a Member of IAWA (international Aviation Women Association) and of ” Institut Français des Administrateurs “.
Elisabeth was awarded Chevalier de la Légion d’Honneur in 2010. 


Nicolas Conti, Ph.D. - Member

Nicholas Conti joined Quest Diagnostics in 2006 as the Deputy Chairman in charge of licensing agreements, technological partnerships and the development and management of strategic alliances. He has been involved in a large number of mergers and acquisitions.

Nicholas has over 16 years of experience in the medical equipment and diagnostics sector. He was Deputy Chairman of Business Development at Becton Dikson, where he managed projects dealing with licensing agreements, strategic planning and the creation of new engines of growth.

He began his career, and spent 10 years, with Union Carbide as a researcher in their plastics division. He went on to become the division's coordinator for catalysis research before obtaining his MBA from the Wharton Business School. He subsequently joined the central division in the licensing agreements, mergers and acquisitions, and dispositions sectors. His team was in charge of a $100M budget for licensing agreements worldwide. Nicholas Conti completed a chemistry degree at the University of Notre Dame and a doctorate in chemistry at the University of Florida. He also holds an MBA from the University of Pennsylvania's Wharton Business School.


Stéphane Verdood, M.Sc., MBA - Member

Currently a Partner at Vesalius Biocapital, Stéphane Verdood has 25 years’ experience as a Business Consultant in the healthcare, pharmaceutical and biotechnology industries. He co-founded Value for Growth in 2001 as a venture coach for mainly young biotechnology companies and has assisted more than 10 start-up companies in fundraising. Stéphane worked for more than 15 years at Arthur Andersen as a business consultant to the pharmaceutical industry. He successfully merged and reorganized hospitals in Europe and re-structured European pharmaceutical companies in the areas of R&D, distribution and sales. In 1995 he founded Andersen Business Consulting in Belgium.

Stéphane holds a M.Sc. in commercial engineering as well as a MBA from the University of Leuven.


Tamar Saraga - Member

Currently as International Executive Advisor in Mergers & Acquisitions and Strategy, Tamar Saraga is helping Corporations and Startups to improve their operations and grow their business in cross-border Mergers & Acquisitions, Strategy, Scouting and EMEA Business Development. She is also an advisor and mentor in several Startups Accelerators. 

With a proven experience of 25 years in the High Technology Industry in international executive positions, she is a former executive of Oracle Corporation where she spent 15 years (1996-2011), lately as Europe, Middle East and Africa M&A and Strategy Senior Director and previously as Chief Operating Officer (COO) of ORACLE France. Tamar has led dozens of local and cross-borders M&A projects to success since 2004 and has managed the multi years Strategic Plan for Oracle EMEA from the definition phase up to the follow up of its execution across 60 countries and among the 22000 employees of the organization  generating 11.5B$ revenue per year.
Tamar is graduated from the Technion, Israel Institute of Technology with a B.Sc degree in Computer Sciences and Information Systems.

Beth Jacobs - Member 

Beth Jacobs currently serves as Managing Partner of Excellentia Global Partners (EGP), a global life sciences investment bank. EGP works closely with early stage biotech and medical device companies, raising capital and enabling licensing and partnering with Pharma companies.  Prior to establishing EGP, Beth was a General Partner at Bio-IB, a life science-focused investment bank.

Beth has served in senior executive roles in her twenty five years of experience in both investment banking and in the corporate sector.  Prior to 2003, Beth was Managing Director and Co-Head of Global Capital Markets at ING Barings. She started her career at Prudential Securities where she founded the international institutional equity business, Furman Selz, later aquired by ING Barings. She later headed the same product execution group at both Morgan Stanley and Lehman Brothers.

She currently serves on the Board of Governors of the New York Academy of Sciences, founding Global Ambassador for Susan G. Komen for the Cure, and Board member for the Harvard Kennedy School of Government Women’s Leadership Board.

Beth received an MBA in international finance from American University in Washington, DC in conjunction with the School of Foreign Service, and a BA, cum laude, from Boston College.